Skip to main content
TipRanks
Go Ultimate75% OFF

Regenerative Medical Technology Group (RMTG) Ratios

6 Followers

Regenerative Medical Technology Group Ratios

RMTG's free cash flow for Q2 2026 was $288.48K. For the 2026 fiscal year, RMTG's free cash flow was decreased by $-43.50K and operating cash flow was $331.97K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.030.040.030.140.72
Quick Ratio0.030.040.030.140.71
Cash Ratio0.030.040.020.140.71
Solvency Ratio-0.19-0.17-0.39-0.27-0.80
Operating Cash Flow Ratio-0.020.03-0.02-0.09-2.34
Short-Term Operating Cash Flow Coverage-0.040.05-0.03-0.16-6.47
Net Current Asset Value$ -38.01M$ -29.93M$ -24.10M$ -18.37M$ -13.04M
Leverage Ratios
Debt-to-Assets Ratio4.365.256.131.871.44
Debt-to-Equity Ratio-0.56-0.73-0.81-1.26-1.98
Debt-to-Capital Ratio-1.29-2.74-4.264.792.02
Long-Term Debt-to-Capital Ratio-0.07-0.09-0.13-2.062.33
Financial Leverage Ratio-0.13-0.14-0.13-0.67-1.38
Debt Service Coverage Ratio-0.000.01-0.14-0.09-2.38
Interest Coverage Ratio-0.120.01-0.11-0.27-3.65
Debt to Market Cap31.6156.14194.2465.214.31
Interest Debt Per Share2.142.051.941.601.40
Net Debt to EBITDA-222.7362.58-5.68-13.25-1.03
Profitability Margins
Gross Profit Margin55.11%68.73%69.53%57.31%34.29%
EBIT Margin-7.15%1.98%-137.85%-76.55%-2317.25%
EBITDA Margin-1.64%7.35%-124.98%-66.57%-2307.92%
Operating Profit Margin-17.00%1.98%-29.68%-77.43%-2268.34%
Pretax Profit Margin-153.18%-135.43%-407.21%-364.33%-2942.42%
Net Profit Margin-153.18%-135.43%-407.21%-358.99%-2942.42%
Continuous Operations Profit Margin-153.18%-135.43%-407.21%-364.33%-2939.41%
Net Income Per EBT100.00%100.00%100.00%98.53%100.00%
EBT Per EBIT900.92%-6852.55%1372.10%470.53%129.72%
Return on Assets (ROA)-174.05%-145.57%-340.86%-67.98%-138.46%
Return on Equity (ROE)22.48%20.33%45.03%45.85%190.68%
Return on Capital Employed (ROCE)2.68%-0.32%3.69%30.23%-195.24%
Return on Invested Capital (ROIC)5.71%-1.11%17.26%-37.11%-150.15%
Return on Tangible Assets-284.37%-280.61%-1041.15%-286.00%-422.65%
Earnings Yield-1261.94%-1557.60%-10800.42%-2366.07%-415.60%
Efficiency Ratios
Receivables Turnover116.41181.71100.6030.7525.38
Payables Turnover6.571.011.742.661.59
Inventory Turnover14.37126.980.000.0011.87
Fixed Asset Turnover3.425.656.666.9519.11
Asset Turnover1.141.070.840.190.05
Working Capital Turnover Ratio-0.16-0.17-0.15-0.27-0.42
Cash Conversion Cycle-27.01-356.49-205.81-125.28-185.01
Days of Sales Outstanding3.142.013.6311.8714.38
Days of Inventory Outstanding25.392.870.000.0030.75
Days of Payables Outstanding55.54361.38209.44137.15230.15
Operating Cycle28.534.883.6311.8745.14
Cash Flow Ratios
Operating Cash Flow Per Share-0.060.07-0.03-0.09-0.86
Free Cash Flow Per Share-0.100.05-0.06-0.11-0.86
Dividend Paid and CapEx Coverage Ratio-1.173.95-1.09-5.61-2469666.00
Capital Expenditure Coverage Ratio-1.173.95-1.09-5.61-2469666.00
Operating Cash Flow Coverage Ratio-0.040.04-0.02-0.07-0.74
Operating Cash Flow to Sales Ratio-0.140.21-0.17-0.73-22.56
Free Cash Flow Yield-211.46%177.87%-885.72%-565.34%-318.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.08-0.06-0.01-0.04-0.24
Price-to-Sales (P/S) Ratio0.120.090.040.157.08
Price-to-Book (P/B) Ratio-0.02-0.01-0.00-0.02-0.46
Price-to-Free Cash Flow (P/FCF) Ratio-0.470.56-0.11-0.18-0.31
Price-to-Operating Cash Flow Ratio-0.880.42-0.22-0.21-0.31
Price-to-Earnings Growth (PEG) Ratio-0.000.00-0.000.00-0.00
Enterprise Value Multiple-230.1463.77-5.71-13.48-1.34
Enterprise Value19.23M19.24M17.21M13.73M13.49M
EV to EBITDA-230.1463.77-5.71-13.48-1.34
EV to Sales3.774.687.148.9730.82
EV to Free Cash Flow-14.6930.29-21.39-10.46-1.37
EV to Operating Cash Flow-27.2222.62-41.06-12.32-1.37
Tangible Book Value Per Share-2.89-2.33-1.91-1.48-1.13
Shareholders’ Equity Per Share-2.75-2.18-1.75-0.98-0.59
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.400.330.190.130.04
Net Income Per Share-0.62-0.44-0.79-0.45-1.12
Tax Burden1.001.001.000.991.00
Interest Burden21.43-68.532.954.761.27
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.630.580.661.0422.62
Stock-Based Compensation to Revenue0.000.000.000.010.64
Income Quality0.09-1.330.040.200.77

Currency in USD